Evaluation of the association of chronic inflammation and cancer: Insights and implications

Among the most extensively researched processes in the development and treatment of cancer is inflammatory condition. Although acute inflammation is essential for the wound healing and reconstruction of tissues that have been damaged, chronic inflammation may contribute to the onset and growth of a number of diseases, including cancer. By disrupting the signaling processes of cells, which result in cancer induction, invasion, and development, a variety of inflammatory molecules are linked to the development of cancer. The microenvironment surrounding the tumor is greatly influenced by inflammatory cells and their subsequent secretions, which also contribute significantly to the tumor's growth, survivability, and potential migration. These inflammatory variables have been mentioned in several publications as prospective diagnostic tools for anticipating the onset of cancer. Targeting inflammation with various therapies can reduce the inflammatory response and potentially limit or block the proliferation of cancer cells. The scientific medical literature from the past three decades has been studied to determine how inflammatory chemicals and cell signaling pathways related to cancer invasion and metastasis are related. The current narrative review updates the relevant literature while highlighting the specifics of inflammatory signaling pathways in cancer and their possible therapeutic possibilities.

Automated summary

One of the most extensively studied processes in cancer development and treatment is inflammation. While acute inflammation is necessary for wound healing and tissue reconstruction, chronic inflammation may contribute to the onset and growth of cancer. Inflammatory molecules disrupt cell signaling processes that lead to cancer induction, invasion, and development. The tumor microenvironment is greatly influenced by inflammatory cells and their secretions, which also play a significant role in tumor growth, survivability, and potential migration. Targeting inflammation with various therapies can reduce the inflammatory response and potentially inhibit the proliferation of cancer cells.